Literature DB >> 17301468

Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner.

Hugo W A M de Jong1, Floris H P van Velden, Reina W Kloet, Fred L Buijs, Ronald Boellaard, Adriaan A Lammertsma.   

Abstract

The ECAT high resolution research tomograph (HRRT) is a dedicated brain and small animal PET scanner, with design features that enable high image spatial resolution combined with high sensitivity. The HRRT is the first commercially available scanner that utilizes a double layer of LSO/LYSO crystals to achieve photon detection with depth-of-interaction information. In this study, the performance of the commercial LSO/LYSO HRRT was characterized, using the NEMA protocol as a guideline. Besides measurement of spatial resolution, energy resolution, sensitivity, scatter fraction, count rate performance, correction for attenuation and scatter, hot spot recovery and image quality, a clinical evaluation was performed by means of a HR+/HRRT human brain comparison study. Point source resolution varied across the field of view from approximately 2.3 to 3.2 mm (FWHM) in the transaxial direction and from 2.5 to 3.4 mm in the axial direction. Absolute line-source sensitivity ranged from 2.5 to 3.3% and the NEMA-2001 scatter fraction equalled 45%. Maximum NECR was 45 kcps and 148 kcps according to the NEMA-2001 and 1994 protocols, respectively. Attenuation and scatter correction led to a volume uniformity of 6.3% and a system uniformity of 3.1%. Reconstructed values deviated up to 15 and 8% in regions with high and low densities, respectively, which can possibly be assigned to inaccuracies in scatter estimation. Hot spot recovery ranged from 60 to 94% for spheres with diameters of 1 to 2.2 cm. A high quantitative agreement was met between HR+ and HRRT clinical data. In conclusion, the ECAT HRRT has excellent resolution and sensitivity properties, which is a crucial advantage in many research studies.

Entities:  

Mesh:

Year:  2007        PMID: 17301468     DOI: 10.1088/0031-9155/52/5/019

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  102 in total

1.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

Review 2.  Molecular brain imaging in the multimodality era.

Authors:  Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

3.  Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.

Authors:  Irene Neuner; Joachim B Kaffanke; Karl-Josef Langen; Elena Rota Kops; Lutz Tellmann; Gabriele Stoffels; Christoph Weirich; Christian Filss; Jürgen Scheins; Hans Herzog; N Jon Shah
Journal:  Eur Radiol       Date:  2012-07-11       Impact factor: 5.315

4.  Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.

Authors:  Yilong Ma; Tom H Johnston; Shichun Peng; Chuantao Zuo; James B Koprich; Susan H Fox; Yihui Guan; David Eidelberg; Jonathan M Brotchie
Journal:  Mov Disord       Date:  2015-08       Impact factor: 10.338

5.  Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

Authors:  Andrea Varrone; Nils Sjöholm; Lars Eriksson; Balazs Gulyás; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

Review 6.  The potential of PET/MR for brain imaging.

Authors:  Wolf-Dieter Heiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

7.  Evaluation of frame-based and event-by-event motion-correction methods for awake monkey brain PET imaging.

Authors:  Xiao Jin; Tim Mulnix; Christine M Sandiego; Richard E Carson
Journal:  J Nucl Med       Date:  2014-01-16       Impact factor: 10.057

8.  Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.

Authors:  Robert H Pietrzak; Jean-Dominique Gallezot; Yu-Shin Ding; Shannan Henry; Marc N Potenza; Steven M Southwick; John H Krystal; Richard E Carson; Alexander Neumeister
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

9.  Neuroimaging of mirtazapine enantiomers in humans.

Authors:  Donald F Smith; Søren B Hansen; Steen Jakobsen; Dirk Bender; Hélène Audrain; Mahmoud Ashkanian; Bo S Stork; Luciano Minuzzi; Håkan Hall; Raben Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

10.  Pretreatment brain states identify likely nonresponse to standard treatments for depression.

Authors:  Callie L McGrath; Mary E Kelley; Boadie W Dunlop; Paul E Holtzheimer; W Edward Craighead; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2013-12-19       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.